Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,430.00
0.00 (0.00%)
At close: Oct 2, 2025

Korean Drug Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
62,74473,00181,37579,98474,46666,789
Upgrade
Other Revenue
---0-0-0-
Upgrade
62,74473,00181,37579,98474,46666,789
Upgrade
Revenue Growth (YoY)
-19.48%-10.29%1.74%7.41%11.49%20.28%
Upgrade
Cost of Revenue
34,97138,60044,02545,46743,40038,100
Upgrade
Gross Profit
27,77434,40137,35034,51731,06528,689
Upgrade
Selling, General & Admin
23,33624,13718,13619,11118,52916,530
Upgrade
Other Operating Expenses
546.96677.64724.2662745.93662.9
Upgrade
Operating Expenses
24,36730,29630,63020,18819,79917,650
Upgrade
Operating Income
3,4074,1056,72014,32911,26611,039
Upgrade
Interest Expense
-3.98-4.24-3.02-2.1-1.53-3.13
Upgrade
Interest & Investment Income
671.45594.691,213621.01133.66166.91
Upgrade
Earnings From Equity Investments
------576.86
Upgrade
Currency Exchange Gain (Loss)
6.373.481.5584.7398.22-74.65
Upgrade
Other Non Operating Income (Expenses)
210.41218.47205.8832.88182.37227.81
Upgrade
EBT Excluding Unusual Items
4,2914,9178,13715,06611,67910,779
Upgrade
Gain (Loss) on Sale of Investments
11.172.9132.87-383.6-359.46-1,534
Upgrade
Gain (Loss) on Sale of Assets
3.873.56-4.782.811.13-5.28
Upgrade
Pretax Income
4,3064,9948,26514,68511,3219,240
Upgrade
Income Tax Expense
756.971,99813,1822,8762,2781,880
Upgrade
Net Income
3,5492,995-4,91711,8099,0427,360
Upgrade
Net Income to Common
3,5492,995-4,91711,8099,0427,360
Upgrade
Net Income Growth
---30.59%22.86%88.94%
Upgrade
Shares Outstanding (Basic)
111111111111
Upgrade
Shares Outstanding (Diluted)
111111111111
Upgrade
Shares Change (YoY)
0.22%0.08%-0.01%-1.30%0.56%-0.33%
Upgrade
EPS (Basic)
328.41277.55-455.981095.09827.64677.40
Upgrade
EPS (Diluted)
328.41277.55-455.981095.09827.64677.40
Upgrade
EPS Growth
---32.31%22.18%89.57%
Upgrade
Free Cash Flow
8,9323,842-2,119-180.157,66011,592
Upgrade
Free Cash Flow Per Share
826.44356.01-196.53-16.71701.121066.91
Upgrade
Gross Margin
44.27%47.12%45.90%43.16%41.72%42.95%
Upgrade
Operating Margin
5.43%5.62%8.26%17.91%15.13%16.53%
Upgrade
Profit Margin
5.66%4.10%-6.04%14.76%12.14%11.02%
Upgrade
Free Cash Flow Margin
14.24%5.26%-2.60%-0.22%10.29%17.36%
Upgrade
EBITDA
5,4136,1748,46915,71212,73612,394
Upgrade
EBITDA Margin
8.63%8.46%10.41%19.64%17.10%18.56%
Upgrade
D&A For EBITDA
2,0062,0691,7491,3831,4701,355
Upgrade
EBIT
3,4074,1056,72014,32911,26611,039
Upgrade
EBIT Margin
5.43%5.62%8.26%17.91%15.13%16.53%
Upgrade
Effective Tax Rate
17.58%40.02%159.49%19.58%20.13%20.35%
Upgrade
Advertising Expenses
-900.89920.231,0141,0821,231
Upgrade
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.